Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-07

Clinical Trial Update: Remotely Supervised tDCS for Slowing ALS Disease Progression [NA]

View source ↗

Summary

A completed clinical trial evaluated remotely supervised transcranial direct current stimulation (tDCS) to slow progression in amyotrophic lateral sclerosis (AL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Amyotrophic Lateral Sclerosis (ALS) | NA | Status: COMPLETED | Results posted: 2025-08-07